VBI Vaccines Inc/BC Annual Net Income (Loss) Attributable to Parent in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
VBI Vaccines Inc/BC quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2015 to 2023.
  • VBI Vaccines Inc/BC Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$17.9M, a 35.5% increase year-over-year.
  • VBI Vaccines Inc/BC Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$83M, a 30.7% increase year-over-year.
  • VBI Vaccines Inc/BC annual Net Income (Loss) Attributable to Parent for 2023 was -$92.8M, a 18.1% increase from 2022.
  • VBI Vaccines Inc/BC annual Net Income (Loss) Attributable to Parent for 2022 was -$113M, a 62.4% decline from 2021.
  • VBI Vaccines Inc/BC annual Net Income (Loss) Attributable to Parent for 2021 was -$69.8M, a 50.9% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$92.8M +$20.5M +18.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-16
2022 -$113M -$43.6M -62.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-16
2021 -$69.8M -$23.5M -50.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-13
2020 -$46.2M +$8.58M +15.7% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-07
2019 -$54.8M +$8.79M +13.8% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-02
2018 -$63.6M -$24.6M -63.1% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-05
2017 -$39M -$15.8M -68% Jan 1, 2017 Dec 31, 2017 10-K 2019-02-25
2016 -$23.2M +$2.99M +11.4% Jan 1, 2016 Dec 31, 2016 10-K 2018-02-26
2015 -$26.2M Jan 1, 2015 Dec 31, 2015 10-K 2018-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.